Abstract
Skeletal uptake of 99mTc-labelled diphosphonate depends primarily upon osteoblastic activity and, to a lesser extent, skeletal vascularity (Fogelman 1980). A bone scan image therefore presents a functional display of total skeletal metabolism and as such has a potentially valuable role to play in the assessment of patients with metabolic bone disorders. However, the bone scan appearances in metabolic bone disease are often non-specific, and their recognition depends upon a subjective impression of increased tracer uptake throughout the whole skeleton (Fogelman and Citrin 1981). This may be particularly difficult to detect when dealing with mild disease. It is the presence of focal lesions, as in metastatic disease, that makes a bone scan appear obviously abnormal. While focal lesions are easily identified, slightly increased tracer uptake throughout the whole skeleton may be virtually impossible to detect by visual inspection alone.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alberts C, Van der Schoot JB, Busemann-Sokole E (1981) Bone scintigraphy and densitometry in symptomatic haemodialysis bone disease. Eur J Nucl Med 6: 505–509
Ali A, Tetalman MR, Fordham EW et al. (1980) Distribution of hypertrophic pulmonary osteoarthropathy. Am J Radiol 134: 771–780
Briancon D, Meunier PJ (1981) Treatment of osteoporosis with fluoride, calcium and vitamin D. Orthop Clin North Am 12: 629–648
Cavalli PL, Camuzzini GF, Ghezzi P, Palanca R, Rovere A, Tortore P (1976) Total body gammagraphy in uraemic patients. Minerva Nefrol 23: 142–148
de Graaf P, Schicht IM, Pauwels EK, te Velde J, de Graeff J (1978) Bone scintigraphy in renal osteodystrophy. J Nucl Med 19: 1289–1296
de Graaf P, Schicht IM, Pauwels EKJ, Souverijn JHM, de Graeff J (1979) Bone scintigraphy in uremic pulmonary calcification. J Nucl Med 20: 201–206
de Graaf P, Pauwels EKJ, Vos PH, Schicht IM, te Velde J, de Graeff J (1984) Observations on computerized quantitative bone scintigraphy in renal osteodystrophy. Eur J Nucl Med 9: 419–425
Devacaanthan K, Yap AU, Chayes Z, Stein RM (1976) Pulmonary calcification in chronic renal failure; use of diphosphonate scintiscan as a diagnostic tool. Clin Nephrol 6: 488–491
Duraler F, Vulpetti AT, Guise ER, Levin NM (1977) 18F -scintigraphy in the early diagnosis of osteonecrosis of the femoral head in chronic haemodialysis and transplantation. Clin Nephrol 8: 349–353
Evens RG, Ashburn W, Bartter FC (1969) Strontium 85 scanning of a “brown tumour” in a patient with parathyroid carcinoma. Br J Radiol 42: 224–225
Fogelman I (1980) Skeletal uptake of diphosphonate: a review. Eur J Nucl Med 3: 473–476
Fogelman I, Boyle IT (1980) Bone scanning in clinical practice. Scott Med J 25: 45–49
Fogelman I, Carr D (1980) A comparison of bone scanning and radiology in the evaluation of patients with metabolic bone disease. Clin Radiol 31: 321–326
Fogelman I, Citrin DL (1981) Bone scanning in metabolic bone disease: a review. Appl Radiol 10: 158–166
Fogelman I, McKillop JH, Greig WR, Boyle IT (1977a) Pseudofracture of the ribs detected by bone scanning. J Nucl Med 18: 1236–1237
Fogelman I, McKillop JH, Cowden EA, Fine A, Boyce B, Boyle ET, Greig WR (1977b) Bone scan findings in hypervitaminosis D: case report. J Nucl Med 18: 1205–1207
Fogelman I, McKillop JH, Bessent RG, Boyle IT, Turner JG, Greig WR (1978a) The role of bone scanning in osteomalacia. J Nucl Med 19: 245–248
Fogelman I, Bessent RG, Turner JG, Citrin DL, Boyle IT, Greig WR (1978b) The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease. J Nucl Med 19: 270–275
Fogelman I, Citrin DL, Turner JG, Hay ID, Bessent RG, Boyle IT (1979) Semi-quantitative interpretation of the bone scan in metabolic bone disease. Eur J Nucl Med 4: 287–289
Fogelman I, Bessent RG, Beastall G, Boyle IT (1980a) Estimation of skeletal involvement in primary hyperparathyroidism. Ann Intern Med 92: 65–67
Fogelman I, Hay ED, Turner JG, Citrin DL, Greig WR (1980b) Semi-quantitative analysis of the bone scan in acromegaly: correlation with human growth hormone values. Br J Radiol 53: 874–877
Fogelman I, McKillop JH, Gray HW (1983) The ‘hot’ patella sign—is it of any clinical significance? J Nucl Med 24: 312–315
Francis MD, Horn PA, Tofe AJ (1981) Controversial mechanism of technetium-99m deposition on bone. J Nucl Med 22: 72 (abstract)
Front D, Hardaoff R, Levy J, Benderly A (1978) Bone scintigraphy in scurvy. J Nucl Med 19: 916–917
Frost HM (1963) Bone remodelling dynamics. Thomas, Springfield, Ill
Hall FM, Goldberg RP, Davies JAK, Fainsinger MH (1980) Scintigraphic assessment of bone islands. Radiology 135: 737–742
Heaney RP (1963) Evaluation and interpretation of calciumkinetic data in man. Clin Orthop 31: 153–183
Kipper MS, Alazraki NP, Feiglin DH (1982) The “hot” patella. Clin Nucl Med 7: 28–32
Kukar N, Sy WM (1981) Selected endocrine disorders. In: Sy WM (ed) Gamma images in benign and metabolic bone diseases, vol H. CRC Press, Boca Raton, Fla, pp 1–21
Leicht E, Berberich R, Lauffenburger T, Haas HG (1979) Tumoral calcinosis: accumulation of bone-seeking tracers in the calcium deposits. Eur J Nucl Med 4: 419–421
Levine SB, Haines JE, Larson SM, Andrews TM (1977) Reduced skeletal localization of 99m-Tc-diphosphonate in two cases of severe osteoporosis. Clin Nucl Med 2: 318–321
Lien JW, Wiegmann T, Rosenthall L, Kaye M (1976) Abnormal 99mtechnetium-tin-pyrophosphate bone scans in chronic renal failure. Clin Nephrol 6: 509–512
Matin P (1979) The appearance of bone scans following fractures, including immediate and long-term studies. J Nucl Med 20: 1227–1231
Nordin BEC, Horsman A, Aaron J (1976) Diagnostic procedures. In: Nordin BEC (ed) Calcium, phosphate and magnesium metabolism. Churchill Livingstone, Edinburgh, pp 469–524
O’Duffy JD, Wahner HW, O’Fallon WM, Johnson KA, Muhs J, Riggs BL (1986). Mechanism of acute lower extremity pain syndrome in fluoride-treated osteoporotic patients. Am J Med 80: 561–566
Olgaard K, Heerfordt J, Madsen S (1976) Scintigraphic skeletal changes in uraemic patients on regular haemodialysis. Nephron 17: 325–334
Olgaard K, Madsen S, Heerfordt J, Hammer M, Jensen H (1979) Scintigraphic skeletal changes in non-dialyzed patients with advanced renal failure. Clin Nephrol 12: 273–278
Park H-M, Lambertus J (1977) Skeletal and reticuloendothelial imaging in osteopetrosis: case report. J Nucl Med 18: 1091–1095
Parkinson IS, Ward MK, Kerr DNS (1981) Dialysis encephalopathy, bone disease and anaemia: the aluminium intoxication syndrome during regular haemodialysis. J Clin Pathol 34: 1285–1294
Riggs BL, Seeman E, Hodgson SF, Taves DR, O’Fallon WM (1982) Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. New Engl J Med 306: 446–450
Rosenbaum RC, Frieri M, Metcalfe DD (1984) Patterns of skeletal scintigraphy and their relationship to plasma and urinary histamine levels in systemic mastocytosis. J Nucl Med 25: 859–864
Rosenthall L, Kaye M (1976) Observations on the mechanisms of 99mTc-labelled phosphate complex uptake in metabolic bone disease. Semin Nucl Med 6: 59–67
Schulz EE, Libanati CR, Farley SM, Kirk GA, Baylink DJ (1984) Skeletal scintigraphic changes in osteoporosis treated with sodium fluoride: concise communication. J Nucl Med 25: 651–655
Singh BN, Kesala BA, Mehta SP, Quinn JL (1977) Osteomalacia on bone scan simulating skeletal metastases. Clin Nucl Med 2: 181–183
Suzuki Y, Hisada K, Takeda M (1974) Demonstration of myositis ossificans by 99mTc pyrophosphate bone scanning. Radiology 111: 663–664
Sy WM (1974) Bone scan in primary hyperparathyroidism. J Nucl Med 15: 1089–1091
Sy WM (ed) (1981) Osteoporosis. In: Gamma images in benign and metabolic bone diseases. CRC Press, Boca Raton, Fla, pp 223–239
Sy WM, Mittal AK (1975) Bone scan in chronic dialysis patients with evidence of secondary hyperparathyroidism and renal osteodystrophy. Br J Radiol 48: 878–884
Sy WM, Smith AJ (1981) Chronic renal dialysis. In: Sy WM (ed) Gamma images in benign and metabolic bone diseases. CRC Press, Boca Raton, Fla, pp 151–186
Sy WM, Bonventure MV, Camera A (1976) Bone scan in mastocytosis: case report. J Nucl Med 17: 699–701
Sy WM, Mottola O, Lao RS, Smith A, Freund HR (1977) Unusual bone images in hyperparathyroidism. Br J Radiol 50: 740–744
Tyler JL, Derbekyan V, Lisbona R (1984) Early diagnosis of myositis ossificans with Tc-99m diphosphonate imaging. Clin Nucl Med 9: 256–258
Vanherweghem JL, Schoutens A, Bergmann P, Stolear J-C, Abramowicz D, Dhaene M, Smeyers J, Verbeelen D, Fuss M, Kinneart P (1984) Usefulness of 99mTc-pyrophosphate bone scintigraphy in aluminium bone disease. Trace Elements in Medicine 1: 80–83
Whyte MP, Murphy WA, Siegel BA (1978) 99mTc-pyrophosphate bone imaging in osteopoikilosis, osteopathia striata and melorheostosis. Radiology 127: 439–443
Wiegmann T, Rosenthall L, Kaye M (1977) Technetium 99m- pyrophosphate bone scans in hyperparathyroidism. J Nucl Med 18: 231–235
Wilkins WE, Chalmers A, Sanerkin NG, Rowe MJ (1983) Osteomalacia in the elderly: the value of radio-isotope bone scanning in patients with equivocal biochemistry. Age Ageing 12: 195–200
Wilson MA (1981) The effect of age on the quality of bone scans using technetium-99m pyrophosphate. Radiology 139: 703–705
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Fogelman, I. (1987). The Bone Scan in Metabolic Bone Disease. In: Fogelman, I. (eds) Bone Scanning in Clinical Practice. Springer, London. https://doi.org/10.1007/978-1-4471-1407-9_7
Download citation
DOI: https://doi.org/10.1007/978-1-4471-1407-9_7
Publisher Name: Springer, London
Print ISBN: 978-1-4471-1409-3
Online ISBN: 978-1-4471-1407-9
eBook Packages: Springer Book Archive